TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
BUSE

First Busey Corp

Financial Services · Banks - Regional

29.70$ +0.9% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

First Busey Corp (BUSE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 18,192 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BUSE
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
5,592 5,425 5,439 5,531 6,914 7,861 7,779 7,776 7,889 7,702 9,537 9,613 9,754 9,696 9,721 10,836 10,540 10,544 10,760 12,415 12,899 12,860 12,568 12,356 12,497 12,337 12,345 12,209 12,258 12,283 11,887 11,971 11,987 12,047 19,464 18,919 18,189 18,105 18,037 18,192
1,133 927 4,497 940 923 1,220 6,069 1,102 1,024 5,972 2,251 2,271 2,226 2,178 2,109 2,747 2,561 2,950 3,202 4,385 4,881 4,817 3,425 2,975 2,894 2,689 2,659 2,517 2,521 2,807 2,489 2,115 2,372 1,927 1,286 796 430 253 242 665
358 167 440 294 214 348 368 231 161 240 330 420 525 529 343 1,050 480 689 405 921 884 836 479 231 347 227 276 233 338 720 591 285 554 698 1,200 752 385 181 169 665
1,133 926 1,094 940 923 1,231 1,190 1,102 1,024 938 2,251 2,271 2,226 2,178 2,109 2,747 2,561 2,950 3,202 4,385 4,881 4,817 3,425 2,975 2,894 2,689 2,659 2,517 2,521 2,807 2,489 2,115 2,372 1,927 1,286 796 430 181 169 665
– – – – – – – – – – – – – 6,634 6,661 7,133 7,022 6,713 6,685 7,090 – – – – – – – – – – – – – – – – – 72 73 73
269 259 97 169 141 96 30 3.7 1.1 0.4 0.9 0.9 0.9 3.1 3.6 3.8 5.0 4.6 4.3 3.1 3.2 4.4 3.6 1.4 1.2 0.9 – – – – – – – – – – – – – –
80 78 78 79 101 117 119 120 119 118 148 160 154 151 150 147 144 135 133 154 153 147 143 140 138 139 – – – – – – – – – – – – – –
102 103 103 103 219 269 268 268 268 268 314 314 323 312 312 312 312 312 312 318 318 318 318 318 318 318 318 318 318 318 318 333 333 334 385 382 383 383 382 382
20 18 17 16 29 39 37 36 34 33 63 61 59 62 59 57 54 52 50 64 61 58 55 52 49 46 44 41 38 36 34 37 35 32 111 106 102 97 93 89
4,996 4,848 4,837 4,918 6,078 6,944 6,837 6,818 6,917 6,707 8,351 8,409 8,538 8,510 8,504 9,600 9,284 9,274 9,494 11,070 11,566 11,541 11,349 11,194 11,391 11,191 11,146 11,007 11,068 11,011 10,605 10,638 10,584 10,663 17,285 16,506 15,740 15,636 15,624 15,809
4,796 4,638 4,686 4,623 5,805 6,651 6,611 6,554 6,651 6,488 8,011 8,055 8,163 8,116 8,162 9,129 8,849 8,858 9,089 10,575 11,077 11,056 10,865 10,642 10,852 10,652 10,628 10,478 10,528 10,491 10,107 10,116 10,072 10,138 16,608 15,960 15,217 3,826 331 176
459 264 163 229 432 525 463 390 456 20 248 222 232 214 189 219 206 180 215 237 259 288 273 245 251 581 827 415 196 199 147 140 128 156 149 158 147 173 331 176
4,337 4,374 4,486 4,394 5,373 6,126 6,331 6,164 6,196 6,249 7,763 7,833 7,930 7,902 7,973 8,910 8,643 8,678 8,874 10,337 10,818 10,769 10,592 10,397 10,601 10,071 – – – – – – – – – – – – – –
151 71 151 249 225 225 225 225 220 220 259 257 170 170 170 293 293 294 294 346 343 340 337 389 327 324 321 318 316 313 295 302 302 303 384 267 267 284 294 251
596 594 602 613 836 935 942 957 972 995 1,186 1,204 1,216 1,220 1,218 1,236 1,256 1,270 1,266 1,346 1,333 1,319 1,218 1,162 1,107 1,146 1,199 1,202 1,190 1,272 1,283 1,334 1,403 1,383 2,180 2,413 2,449 2,469 2,413 2,383
-169 -164 -156 -146 -136 -132 -119 -105 -88 -72 -57 -45 -32 -15 -28 -14 4.7 21 46 63 76 92 108 125 147 169 192 208 225 237 248 262 280 294 249 274 303 337 359 395
39 39 39 39 46 49 49 49 49 49 54 56 56 55 55 55 55 55 55 56 57 56 56 56 56 56 56 56 56 56 56 58 58 58 70 91 61 89 89 89

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?